133 related articles for article (PubMed ID: 3553215)
1. Transforming growth factors and control of neoplastic cell growth.
Keski-Oja J; Leof EB; Lyons RM; Coffey RJ; Moses HL
J Cell Biochem; 1987 Feb; 33(2):95-107. PubMed ID: 3553215
[TBL] [Abstract][Full Text] [Related]
2. Effect of phorbol esters on the activity of purified transforming growth factors.
Kraft AS
Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factors.
Roberts AB; Sporn MB
Cancer Surv; 1985; 4(4):683-705. PubMed ID: 2890434
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
Anzano MA; Roberts AB; Meyers CA; Komoriya A; Lamb LC; Smith JM; Sporn MB
Cancer Res; 1982 Nov; 42(11):4776-8. PubMed ID: 6290046
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture.
McMahon JB; Richards WL; del Campo AA; Song MK; Thorgeirsson SS
Cancer Res; 1986 Sep; 46(9):4665-71. PubMed ID: 3089593
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factors from neoplastic and nonneoplastic tissues.
Roberts AB; Frolik CA; Anzano MA; Sporn MB
Fed Proc; 1983 Jun; 42(9):2621-6. PubMed ID: 6303865
[TBL] [Abstract][Full Text] [Related]
7. Sarcoma growth factor and other transforming peptides produced by human cells: interactions with membrane receptors.
Todaro GJ; De Larco JE; Fryling CM
Fed Proc; 1982 Nov; 41(13):2996-3003. PubMed ID: 6292003
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin.
Piazza GA; Ritter JL; Baracka CA
Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633
[TBL] [Abstract][Full Text] [Related]
9. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
[TBL] [Abstract][Full Text] [Related]
10. Functional and structural characteristics of EGF and its receptor and their relationship to transforming proteins.
Stoscheck CM; King LE
J Cell Biochem; 1986; 31(2):135-52. PubMed ID: 3015991
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factors (TGFs): properties and possible mechanisms of action.
Todaro GJ; De Larco JE; Fryling C; Johnson PA; Sporn MB
J Supramol Struct Cell Biochem; 1981; 15(3):287-301. PubMed ID: 6267317
[TBL] [Abstract][Full Text] [Related]
12. Orthovanadate both mimics and antagonizes the transforming growth factor beta action on normal rat kidney cells.
Rijksen G; Völler MC; Van Zoelen EJ
J Cell Physiol; 1993 Feb; 154(2):393-401. PubMed ID: 8425920
[TBL] [Abstract][Full Text] [Related]
13. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
14. Presence of transforming growth factors in human breast cancer cells.
Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
[TBL] [Abstract][Full Text] [Related]
15. Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis.
Fynan TM; Reiss M
Crit Rev Oncog; 1993; 4(5):493-540. PubMed ID: 8241322
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
Koli K; Keski-Oja J
Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362
[TBL] [Abstract][Full Text] [Related]
17. Study of events leading cellular senescence to human mammary epithelial cancer cells in vitro.
Saxena S; Jain AK; Bhatnagar D
Indian J Cancer; 2001; 38(2-4):103-16. PubMed ID: 12593448
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor (TGF) activity in human urine: synergism between TGF-beta and urogastrone.
Twardzik DR; Sherwin SA
J Cell Biochem; 1985; 28(4):289-97. PubMed ID: 2997242
[TBL] [Abstract][Full Text] [Related]
19. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
[TBL] [Abstract][Full Text] [Related]
20. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
